This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2014-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Menges, SI (2014 - 2017)
- Ljubljana, SI (2019)
Company Filing History:
Years Active: 2014-2019
Title: Tanja Ficko Trcek: Innovator in Cell Culture Technology
Introduction
Tanja Ficko Trcek is a prominent inventor based in Menges, Slovenia. She has made significant contributions to the field of biotechnology, particularly in the development of cell culture media and processes. With a total of 4 patents to her name, her work has advanced the understanding and application of polypeptide production.
Latest Patents
One of her latest patents is titled "Cell culture medium and process for controlling α-amidation and/or C-terminal amino acid cleavage of polypeptides." This invention focuses on a cell culture medium designed to reduce the C-terminal heterogeneity of polypeptides expressed in cell culture. The medium includes at least one essential trace element in an effective amount, which plays a crucial role in the cell culture process. Another notable patent is "Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content." This invention relates to a cultivation medium for eukaryotic cells, incorporating additives such as DMSO, N-acetylmannosamine (NAcMan), and N-acetylglucosamine (NAcGlc) to enhance glycoprotein production.
Career Highlights
Tanja Ficko Trcek is currently associated with Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. Her work at Lek Pharmaceuticals has allowed her to apply her innovative ideas in a practical setting, contributing to advancements in pharmaceutical research and development.
Conclusion
Tanja Ficko Trcek is a trailblazer in the field of biotechnology, with her patents reflecting her commitment to improving cell culture technologies. Her contributions are vital for the ongoing development of biopharmaceuticals and the enhancement of production processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile